 |
Doug Macron is the editor of GenomeWeb's Gene Silencing News. He covers research and therapeutic applications of RNAi, miRNA, and other gene-silencing technologies. E-mail Doug Macron or follow his GenomeWeb Twitter account at @Genesilencing. |
Court Denies Santaris Bid to End Isis Patent-Infringement Case
September 27, 2012
Court Denies Santaris Bid to End Isis Patent-Infringement Case
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Pfizer Aims to Head Off Court Hearing over Isis, Santaris Patent Dispute
April 11, 2013 / Gene Silencing News - Pfizer, Shire Pulled into Isis Suit Against Santaris with Subpoena Dispute
March 14, 2013 / Gene Silencing News - Isis Opposes Santaris Bid to Throw out Patent-Infringement Suit
March 29, 2012 / Gene Silencing News - Santaris Seeks Dismissal of Isis Patent-Infringement Suit
February 2, 2012 / Gene Silencing News - In Countersuit, Santaris Aims to Invalidate Isis Gapmer Patents
December 15, 2011 / Gene Silencing News